Scribe Therapeutics Inc. (SCTX)

NASDAQ: SCTX · Real-Time Price · USD

28.05

-4.95 (-15.00%)

Sep 21, 2026, 4:00 PM EDT - Market closed

Scribe Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	531	-	-
Market Cap Growth	-	-	-
Enterprise Value	531	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.97	-1.80	-7.57
Net Debt / Equity Ratio	-0.01	0.72	11.54
Net Debt / EBITDA Ratio	-0.01	0.72	1.59
Net Debt / FCF Ratio	-0.01	0.36	1.36
Asset Turnover	-	0.50	-
Quick Ratio	0.56	0.95	3.10
Current Ratio	0.57	0.97	3.15
Return on Assets (ROA)	-	-15.80%	-
Return on Capital Employed (ROCE)	147.80%	-284.50%	-46.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-1.39%	-

SEC Filings: 10-K · 10-Q